• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Olive Compounds Show High Binding Affinity to Leukemia Target in Simulations

by
November 17, 2026
in Cancer, Health
Reading Time: 3 mins read
0
Olive Compounds Show High Binding Affinity to Leukemia Target in Simulations

Olive Compounds Show High Binding Affinity to Leukemia Target in Simulations

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Computational screening and molecular dynamics simulations have identified chemical compounds derived from olive plants that bind with high affinity to a critical enzymatic target involved in leukemia progression. In the study, researchers evaluated compounds originating from Olea europaea against human tRNA-dihydrouridine synthase 2, an enzyme that is overexpressed in malignant cells and plays an essential role in sustaining cancer cell growth. The investigation demonstrated that multiple natural molecules form stable structural complexes with the enzyme, highlighting specific candidates that could inform future therapeutic development against blood cancers.

The biological rationale for targeting human tRNA-dihydrouridine synthase 2, or hDus2, stems from its specific enzymatic activity and elevated presence in neoplastic tissue. Within cellular systems, hDus2 catalyzes the conversion of uridine into dihydrouridine within transfer RNA molecules, facilitating the translational mechanisms essential for the rapid growth and proliferation of cancer cells. Prior biological observations have established that inhibiting hDus2 activity directly reduces cancer cell growth and viability while concurrently enhancing sensitivity to apoptosis under stress conditions, designating the enzyme as an attractive target for therapeutic interventions in leukemia, which ranks among the primary causes of cancer-related fatalities.

To explore potential inhibitors from natural sources, the investigators focused on Olea europaea, a botanical species recognized for harboring diverse secondary metabolites. The plant is known to be rich in flavonoids, polyphenols, vitamins, and antioxidants, conferring broad biological properties that have shown significant value in the context of preventing severe chronic conditions, including cancer and Alzheimer’s disease. Based on these established health-promoting attributes, the research team examined Olea europaea extract for anti-cancer activity before proceeding to computational characterizations designed to isolate and evaluate specific active constituents at the molecular level.

The computational workflow commenced with structure-based virtual screening to identify promising molecular leads from a comprehensive repository of olive constituents. The researchers obtained compound structures from the OliveNet database and screened a total of six hundred seventy-six distinct molecules against the catalytic structure of the hDus2 enzyme. Molecular docking procedures performed with the Glide software module permitted the systematic evaluation of binding orientations and molecular affinities, ultimately revealing that several entries within the library docked strongly into the enzyme target, from which the top five highest-affinity candidate molecules were selected for advanced dynamic modeling.

To rigorously evaluate the structural stability and conformational dynamics of the top five identified candidates, the authors subjected the docked ligand-enzyme complexes to molecular dynamics simulations. These simulations incorporated solvent molecules to closely mimic physiological aqueous environments, allowing the researchers to monitor whether the bound complexes maintained their conformational architecture over time. The computational trajectory analyses confirmed that all five complexes exhibited structural integrity and retained stable conformational dynamics when solvated, validating the initial predictions generated by the docking calculations.

Subsequent binding free energy calculations quantified the thermodynamic favorability of the interactions, demonstrating that all five simulated complexes remained stable throughout testing. Among the evaluated candidates, two specific compounds, designated P166 and P161, exhibited the highest binding potential against the hDus2 enzyme. The authors concluded that these favorable binding characteristics and stable dynamic profiles establish a structural foundation for advancing novel anti-cancer agents directed against hDus2 for the targeted treatment of leukemia.

Subject of Research: In silico identification of olive compounds targeting hDus2 in leukemia

Article Title: Identification of novel compounds from Olea Europaea targeting hDus2 as potential anticancer agents: a molecular docking and molecular dynamics study

Article References: Mukhija, M., Chandra, A., Devi, K., Chaudhuri, S., Bhattacharya, B., Sharma, T., & Goel, V. K. (2026). Identification of novel compounds from Olea Europaea targeting hDus2 as potential anticancer agents: a molecular docking and molecular dynamics study. Frontiers in Oncology, 16, Article 1845700. https://doi.org/10.3389/fonc.2026.1845700

Image Credits: AI Generated

DOI: 10.3389/fonc.2026.1845700

Keywords: Olea europaea, hDus2, tRNA-dihydrouridine synthase 2, leukemia, molecular docking, Glide module, molecular dynamics simulation, OliveNet database, P166, P161, binding free energy, anticancer agents, dihydrouridine, uridine conversion, apoptosis, polyphenols, flavonoids, structure-based virtual screening

News Source: Nathaniel Bowman. (November 17, 2026). Olive Compounds Show High Binding Affinity to Leukemia Target in Simulations. Scienmag.

Tags: anticancer agentsApoptosisbinding free energydihydrouridineflavonoidsGlide modulehDus2leukemiamolecular dockingMolecular dynamics simulationOlea europaeaOliveNet databaseP161P166polyphenolsstructure-based virtual screeningtRNA-dihydrouridine synthase 2uridine conversion
Share12Tweet7Share2ShareShareShare1

Related Posts

Review Reveals Dual Tumor Promoting and Suppressive Functions of Cytoskeletal MYH9

Review Reveals Dual Tumor Promoting and Suppressive Functions of Cytoskeletal MYH9

November 17, 2026
Global Cancer Cases in Older Adults Projected to Nearly Double by 2050

Global Cancer Cases in Older Adults Projected to Nearly Double by 2050

November 17, 2026

Accelerated Biological Aging Predicts Poor Prognosis Following Acute Ischemic Stroke Therapy

November 17, 2026

Case Report Details Cardiac Asystole During Balloon Dilation in Retroperitoneal Laparoscopic Nephrectomy

November 17, 2026

POPULAR NEWS

  • High Prevalence of Gender-Based Violence Follows Armed Conflict in Southern Tigray

    High Prevalence of Gender-Based Violence Follows Armed Conflict in Southern Tigray

    29 shares
    Share 12 Tweet 7
  • Air Pollutants Tied to Adverse Sleep Outcomes Amid Notable Evidence Uncertainty

    29 shares
    Share 12 Tweet 7
  • Network Analysis Identifies Core Positive Development Attributes in Rural Chinese Adolescents

    29 shares
    Share 12 Tweet 7
  • China Silver Economy Policies Show Good Overall Consistency but Uneven Regional Breadth

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Lineage Tracing Overturns Classical Multipotent Models of Mammary Epithelial Cell Hierarchy

Review Reveals Dual Tumor Promoting and Suppressive Functions of Cytoskeletal MYH9

Global Cancer Cases in Older Adults Projected to Nearly Double by 2050

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.